Trials / Completed
CompletedNCT04887610
Factors That Influence Blood Vessel Regulation During Exercise in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Guelph · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study will examine two separate interventions: 1) the effects of ischemic preconditioning or 2) a high fat meal on the capacity of the brachial artery to overcome sympathetic activation and dilate during exercise (also known as functional sympatholysis). Participants will be asked to complete rhythmic handgrip exercise with and without the application of -20 mmHg lower body negative pressure to increase sympathetic activation. Doppler ultrasound will be used to continuously measure brachial artery blood flow. Participants will complete the handgrip exercise and lower body negative pressure before and after the applications of each interventions. Participants may elect to only complete one intervention rather than complete both protocols. Intervention one is active or control ischemic preconditioning. Intervention two is high or low fat meals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ischemic preconditioning | Four 5-minute cycles of 200 mmHg cuff inflation of the brachial artery, each separated by 5-minutes deflated recovery (i.e. 40 minutes total time) |
| PROCEDURE | Ischemic preconditioning control | Four 5-minute cycles of 20 mmHg cuff inflation of the brachial artery, each separated by 5-minutes deflated recovery (i.e. 40 minutes total time) |
| DIETARY_SUPPLEMENT | Low fat meal | Meal containing 1006 calories, 1 g fat, 0.2 g saturated fat, 0 g trans fat, 20 mg cholesterol, 191 g carbohydrates, 60 g protein, 1560 mg sodium |
| DIETARY_SUPPLEMENT | High fat meal | Meal containing 1030 calories, 62 g fat, 23 g saturated fat, 0.5 g trans fat, 445 mg cholesterol, 76 g carbohydrates, 41 g protein, 2080 mg sodium. |
Timeline
- Start date
- 2021-05-20
- Primary completion
- 2022-11-15
- Completion
- 2022-11-15
- First posted
- 2021-05-14
- Last updated
- 2023-03-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04887610. Inclusion in this directory is not an endorsement.